Study of RP-6306 With FOLFIRI in Advanced Solid Tumors

NCT05147350 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

38

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decided to terminate the study

Conditions

Advanced Solid Tumor

Interventions

DRUG: RP-6306 (oral PKMYT1 inhibitor)

Sponsor

Debiopharm International SA

Collaborators

[object Object]